ReviewGalen medical journal2024
Efficacy of Platelet-Rich Plasma and Platelet-Rich Fibrin in Enhancing Dental Implant Osseointegration.
Review in Galen medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The successful integration of dental implants relies on osseointegration, a process essential for implant stability and longevity. Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) have gained attention as biological enhancers for this process due to their high concentrations of growth factors that promote bone regeneration and accelerate healing. This review assesses the efficacy of PRP and PRF in enhancing osseointegration by exploring their biological mechanisms, clinical applications, and advantages for patients with compromised bone or healing potential. Literature indicates that PRP and PRF can improve initial implant stability and accelerate healing. PRP's platelet-derived growth factors (e.g., PDGF, TGF-β, VEGF) stimulate cellular proliferation and angiogenesis, critical for early bone healing. PRF's fibrin-rich matrix provides a sustained release of these factors, supporting prolonged tissue regeneration and soft tissue repair. However, challenges remain, including variability in preparation methods and limited long-term data, underscoring the need for standardized protocols and further research. In conclusion, PRP and PRF demonstrate promise as adjuncts for enhancing dental implant osseointegration, particularly in complex cases. With more evidence and established protocols, they have the potential to become standard tools in implant dentistry, offering improved outcomes and greater predictability in patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.